Jill Greytok

Jill Greytok is the Senior Director of Clinical Development at Hepion Pharmaceuticals. Jill also has experience as the Director, Clinical Development at ContraVir Pharmaceuticals, Inc. where Jill executed global Phase I-III clinical studies of anti-viral therapies. Prior to this, Jill worked as a Medical Science Liaison at Bristol-Myers Squibb for over 25 years. Throughout their career, Jill has been involved in oversight of clinical CRO/vendor selection, contract negotiation, and development of study protocols and other clinical documents associated with IND and CTA submissions.